Molly R. Patterson
Leeds, ENG LS29JT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Inhibition of RNA splicing is a novel therapeutic strategy for disruption of nuclear replicating viruses.
Journal: bioRxiv : the preprint server for biology
Published: July 03, 2026
Replication-competent adenovirus reporters utilizing endogenous viral expression architecture.
Journal: Journal of virology
Published: September 10, 2025
E7-mediated repression of miR-203 promotes LASP1-dependent proliferation in HPV-positive cervical cancer.
Journal: bioRxiv : the preprint server for biology
Published: January 31, 2024
The Hippo pathway transcription factors YAP and TAZ play HPV-type dependent roles in cervical cancer.
Journal: Nature communications
Published: September 11, 2023
m6A Regulates the Stability of Cellular Transcripts Required for Efficient KSHV Lytic Replication.
Journal: Viruses
Published: April 12, 2023
Exploitation of ATP-sensitive potassium ion (KATP) channels by HPV promotes cervical cancer cell proliferation by contributing to MAPK/AP-1 signalling.
Journal: Oncogene
Published: February 14, 2023
CREB1 activation promotes human papillomavirus oncogene expression and cervical cancer cell transformation.
Journal: Journal of medical virology
Published: January 03, 2023
Dysregulation of the miR-30c/DLL4 axis by circHIPK3 is essential for KSHV lytic replication.
Journal: EMBO reports
Published: October 07, 2021
The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation.
Journal: The Journal of general virology
Published: January 11, 2021
The deubiquitinase (DUB) USP13 promotes Mcl-1 stabilisation in cervical cancer.
Journal: Oncogene
Published: July 25, 2020
E6-mediated activation of JNK drives EGFR signalling to promote proliferation and viral oncoprotein expression in cervical cancer.
Journal: Cell death and differentiation
Published: May 29, 2020
Last Updated: 09/26/2026